This quarterly research review provides insights into pharmaceuticals, biopharmaceuticals, medical devices, cell biology, and the healthcare sector. This report summarizes the life sciences landscape, highlighting key market trends, emerging opportunities, and recent regulatory updates. It tracks sustainability trends through data visualizations that display key metrics, including market size and investment flows. It also provides customized research solutions, including syndicated research, targeted market research for specific challenges, and quantitative analysis reports.
Below is a list of reports published in the second quarter of 2026.
Below is a list of reports published in the second quarter of 2026.
- BIO276A Biometrics as a Service in Medical Devices: Global Market
- BIO154B Global Markets for Protein Labeling
- BIO073D Cancer Profiling and Pathways: Technologies and Global Markets
- BIO099G Single-use Technologies for Biopharmaceuticals: Global Markets
- BIO228B Biologic Therapies for Wound Care: Technologies and Global Markets
- HLC214B Chronic Kidney Disease: Global Markets and Technologies
- HLC310A Global Orthopedic Surgical Robots Market
- HLC316A Global Healthcare Fraud Detection Market
- MDS021B Smart Inhalers: Global Markets
- PHM291A Emerging Drugs: Global Markets
- PHM017H In Vitro Toxicity Testing: Technologies and Global Markets
- PHM035D Substance Abuse and Addiction Treatment Global Markets to 2030
- PHM191B Cardiovascular Drugs: Global Markets to 2030
- PHM198C Clinical Nutrition: Global Markets to 2031
Table of Contents
Chapter 1 Industry Lens on Transformation and Growth
Chapter 2 Medical Devices and Surgical - Quarterly Review
Chapter 3 Executive Summary of MDS021B - Smart Inhalers: Global Markets
Chapter 4 Cell Biology - Quarterly Review
Chapter 5 Executive Summary of BIO276A - Biometrics as a Service in Medical Devices: Global Markets
Chapter 6 Executive Summary of BIO154B - Global Markets for Protein Labeling
Chapter 7 Executive Summary of BIO073D - Cancer Profiling and Pathways: Technologies and Global Markets
Chapter 8 Executive Summary of BIO099G - Single-Use Technologies for Biopharmaceuticals: Global Markets
Chapter 9 Executive Summary of BIO228B - Biologic Therapies for Wound Care: Technologies and Global Markets
Chapter 10 Pharmaceuticals - Quarterly Review
Chapter 11 Executive Summary of PHM291A - Emerging Drugs: Global Markets
Chapter 12 Executive Summary of PHM017H - In Vitro Toxicity Testing: Technologies and Global Markets
Chapter 13 Executive Summary of PHM035D - Substance Use Disorder Treatment: Global Markets to 2030
Chapter 14 Executive Summary of PHM191B - Cardiovascular Drugs: Global Markets to 2030
Chapter 15 Executive Summary of PHM198C - Clinical Nutrition: Global Markets to 2031
Chapter 16 Healthcare Maintenance - Quarterly Review
Chapter 17 Executive Summary of HLC214B - Chronic Kidney Disease: Global Markets and Technologies
Chapter 18 Executive Summary of HLC310A- Global Orthopedic Surgical Robots Market
Chapter 19 Executive Summary of HLC316A - Global Healthcare Fraud Detection Market
Chapter 20 Upcoming Reports
List of Tables
List of Figures
Executive Summary
The global smart inhalers market was valued at $5.2 billion in 2024 and is projected to reach $12.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 15.4% from 2025 to 2030.The global market for clinical nutrition was valued at $75.5 billion in 2025 and is projected to reach $104.7 billion by the end of 2031, at a CAGR of 5.6% from 2026 to 2031.
The global market for single-use technologies (SUTs) for biopharmaceuticals was valued at an estimated $8.3 billion in 2025 and is slated to reach $16.3 billion by the end of 2031, at a CAGR of 12.2% from 2026 to 2031.
